NCT06511141

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

RecruitingNAINTERVENTIONAL

Trial Details

Start: 2024-10-22Est. Completion: 2027-12

Enrollment target: 150 participants

Locations

University of Alabama at Birmingham, Birmingham, Alabama, United States
Urology Associates, Fairhope, Alabama, United States
Mayo Clinic, Scottsdale, Arizona, United States
El Camino Health, Mountain View, California, United States
Tri Valley Urology, Murrieta, California, United States
University of Miami, Miami, Florida, United States
Advanced Urology Institute, Oxford, Florida, United States
Louisiana State University, New Orleans, Louisiana, United States
WK Clinical Research, Shreveport, Louisiana, United States
Anne Arundel Urology, Annapolis, Maryland, United States
Mayo Clinic, Rochester, Minnesota, United States
Integrated Medical Professionals, New York, New York, United States
Associated Urologists of North Carolina (AUNC), Raleigh, North Carolina, United States
University Hospitals Cleveland, Cleveland, Ohio, United States
Utica Park Urology, Tulsa, Oklahoma, United States
MidLantic Urology, Bala-Cynwyd, Pennsylvania, United States
Lowcountry Urology Clinics, North Charleston, South Carolina, United States

Urinary Urge Incontinence (UUI)Urinary Frequency (UF)Overactive Bladder (OAB)

Post-market clinical follow-up for continued assessment of safety and performance to confirm long-term outcomes of the A…

Chicago, United StatesEst. completion Jan 2027

Overactive Bladder

The primary objective of this study is to investigate whether providing a standing, take-home prescription for empiric M…

Cleveland, United StatesEst. completion Mar 31, 2028

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.